Specifically, the GLP-1/GIP vial contains four weekly doses each of 2.5 mg, 5 mg, and 7.5 mg, while the GLP-1 vial contains four weekly doses each of 0.25 mg, 0.5 mg, and 1 mg
Microdosing starts at fractions of the lowest prescribed dose and stops that titration early, maintaining a subtherapeutic dose long-term
Since semaglutide slows digestion, some people may not realize they need to drink more fluids
"We call this moving care upstream, getting involved early and partnering with people before they get sick
Results You Can See : Most patients begin to see results within the first few weeks, including weight loss, improved blood sugar levels, and better overall energy and vitality